• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过比较分子场分析(CoMFA)对3,8-二氮杂双环[4.2.0]辛烷衍生物作为神经元烟碱型乙酰胆碱受体进行3D-QSAR和QSSR研究。

3D-QSAR and QSSR studies of 3,8-diazabicyclo[4.2.0]octane derivatives as neuronal nicotinic acetylcholine receptors by comparative molecular field analysis (CoMFA).

作者信息

Ye Mao, Dawson Marcia I

机构信息

Burnham Institute for Medical Research, La Jolla, CA 92037, USA.

出版信息

Bioorg Med Chem Lett. 2009 Jan 1;19(1):127-31. doi: 10.1016/j.bmcl.2008.11.016. Epub 2008 Nov 9.

DOI:10.1016/j.bmcl.2008.11.016
PMID:19026537
Abstract

High subtype selectivity (alpha4beta2 over alpha2beta3) of neuronal nicotinic acetylcholine receptor (nAChR) agonists is critical for the rational design of less toxic drugs used for the treatment of neurodegenerative and psychiatric diseases. Here, three CoMFA models of pEC(50)(alpha4beta2), pEC(50)(alpha2beta3) and p[EC(50)(alpha4beta2)/EC(50)(alpha2beta3)] (pEC(50)(alpha4beta2)pEC(50)(alpha2beta3)) were developed to study the quantitative structure-activity relationship (QSAR) and quantitative structure-selectivity relationship (QSSR) of the 3,8-diazabicyclo[4.2.0]octane derivatives as nAChRs agonists. The parameters of the three models were 0.584, 0.792, and 0.599 for cross-validated r(2) (r(2)(CV)), 0.924, 0.935 and 0.875 for conventional r(2). Analyses indicated that both the steric and electrostatic factors should be considered in the rational design of more active and selective nAChR agonists.

摘要

神经元烟碱型乙酰胆碱受体(nAChR)激动剂的高亚型选择性(α4β2相对于α2β3)对于合理设计用于治疗神经退行性疾病和精神疾病的低毒药物至关重要。在此,开发了pEC(50)(α4β2)、pEC(50)(α2β3)和p[EC(50)(α4β2)/EC(50)(α2β3)](pEC(50)(α4β2)pEC(50)(α2β3))的三个比较分子场分析(CoMFA)模型,以研究作为nAChR激动剂的3,8-二氮杂双环[4.2.0]辛烷衍生物的定量构效关系(QSAR)和定量构选关系(QSSR)。三个模型的参数,交叉验证r(2)(r(2)(CV))分别为0.584、0.792和0.599,传统r(2)分别为0.924、0.935和0.875。分析表明,在合理设计更具活性和选择性的nAChR激动剂时,应同时考虑空间和静电因素。

相似文献

1
3D-QSAR and QSSR studies of 3,8-diazabicyclo[4.2.0]octane derivatives as neuronal nicotinic acetylcholine receptors by comparative molecular field analysis (CoMFA).通过比较分子场分析(CoMFA)对3,8-二氮杂双环[4.2.0]辛烷衍生物作为神经元烟碱型乙酰胆碱受体进行3D-QSAR和QSSR研究。
Bioorg Med Chem Lett. 2009 Jan 1;19(1):127-31. doi: 10.1016/j.bmcl.2008.11.016. Epub 2008 Nov 9.
2
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors.3,6-二氮杂双环[3.1.1]庚烷作为神经元烟碱型乙酰胆碱受体新型配体的合成
Bioorg Med Chem Lett. 2008 Dec 1;18(23):6147-50. doi: 10.1016/j.bmcl.2008.10.002. Epub 2008 Oct 5.
3
3D QSAR analyses-guided rational design of novel ligands for the (alpha4)2(beta2)3 nicotinic acetylcholine receptor.基于3D QSAR分析的新型配体的合理设计,用于(α4)2(β2)3烟碱型乙酰胆碱受体
J Med Chem. 2003 May 22;46(11):2031-48. doi: 10.1021/jm020859m.
4
Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonists.新型α4β2烟碱型乙酰胆碱受体选择性激动剂3,6-二氮杂双环[3.2.0]庚烷的合成及构效关系研究
J Med Chem. 2007 Nov 1;50(22):5493-508. doi: 10.1021/jm070755h. Epub 2007 Oct 11.
5
Structure-activity studies of diazabicyclo[3.3.0]octane-substituted pyrazines and pyridines as potent α4β2 nicotinic acetylcholine receptor ligands.具有二氮杂双环[3.3.0]辛烷取代吡嗪和吡啶结构的化合物作为有效的α4β2 烟碱型乙酰胆碱受体配体的构效关系研究。
J Med Chem. 2011 Nov 10;54(21):7678-92. doi: 10.1021/jm201045m. Epub 2011 Oct 11.
6
The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifs.3,7-二氮杂双环[3.3.1]壬烷骨架作为亚型选择性烟碱型乙酰胆碱受体配体。第 2 部分:具有不同间隔基的羧酰胺衍生物。
Bioorg Med Chem. 2013 Dec 1;21(23):7309-29. doi: 10.1016/j.bmc.2013.09.060. Epub 2013 Oct 5.
7
Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D quantitative structure-activity relationship (QSAR) Models.
Curr Med Chem. 2002 Jan;9(1):1-29. doi: 10.2174/0929867023371463.
8
Discovery of 3-(5-chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a novel highly selective α4β2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders.发现 3-(5-氯-2-呋喃甲酰基)-3,7-二氮杂双环[3.3.0]辛烷(TC-6683,AZD1446),一种新型高选择性的α4β2 烟碱型乙酰胆碱受体激动剂,用于治疗认知障碍。
J Med Chem. 2012 Nov 8;55(21):9181-94. doi: 10.1021/jm3006542. Epub 2012 Jul 27.
9
Epibatidine structure-activity relationships.埃博霉素的构效关系。
Bioorg Med Chem Lett. 2004 Apr 19;14(8):1889-96. doi: 10.1016/j.bmcl.2004.02.007.
10
Synthesis and structure-activity relationships of 3,8-diazabicyclo[4.2.0]octane ligands, potent nicotinic acetylcholine receptor agonists.3,8-二氮杂双环[4.2.0]辛烷配体(强效烟碱型乙酰胆碱受体激动剂)的合成及其构效关系
J Med Chem. 2006 Dec 28;49(26):7843-53. doi: 10.1021/jm060846z.

引用本文的文献

1
3D-QSAR and 3D-QSSR models of negative allosteric modulators facilitate the design of a novel selective antagonist of human α4β2 neuronal nicotinic acetylcholine receptors.三维定量构效关系和三维定量构效关系模型促进了人类α4β2神经元烟碱型乙酰胆碱受体新型选择性拮抗剂的设计。
Bioorg Med Chem Lett. 2012 Feb 15;22(4):1797-813. doi: 10.1016/j.bmcl.2011.11.051. Epub 2011 Nov 20.